1. Home
  2. COEP vs FEAM Comparison

COEP vs FEAM Comparison

Compare COEP & FEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COEP
  • FEAM
  • Stock Information
  • Founded
  • COEP 2017
  • FEAM 2016
  • Country
  • COEP United States
  • FEAM United States
  • Employees
  • COEP N/A
  • FEAM N/A
  • Industry
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • FEAM Major Chemicals
  • Sector
  • COEP Health Care
  • FEAM Industrials
  • Exchange
  • COEP Nasdaq
  • FEAM Nasdaq
  • Market Cap
  • COEP 62.4M
  • FEAM 94.7M
  • IPO Year
  • COEP N/A
  • FEAM N/A
  • Fundamental
  • Price
  • COEP $13.01
  • FEAM $3.82
  • Analyst Decision
  • COEP
  • FEAM Strong Buy
  • Analyst Count
  • COEP 0
  • FEAM 3
  • Target Price
  • COEP N/A
  • FEAM $83.17
  • AVG Volume (30 Days)
  • COEP 45.5K
  • FEAM 129.5K
  • Earning Date
  • COEP 11-12-2025
  • FEAM 11-12-2025
  • Dividend Yield
  • COEP N/A
  • FEAM N/A
  • EPS Growth
  • COEP N/A
  • FEAM N/A
  • EPS
  • COEP N/A
  • FEAM N/A
  • Revenue
  • COEP $263,555.00
  • FEAM N/A
  • Revenue This Year
  • COEP N/A
  • FEAM N/A
  • Revenue Next Year
  • COEP N/A
  • FEAM N/A
  • P/E Ratio
  • COEP N/A
  • FEAM N/A
  • Revenue Growth
  • COEP N/A
  • FEAM N/A
  • 52 Week Low
  • COEP $2.31
  • FEAM $2.82
  • 52 Week High
  • COEP $14.70
  • FEAM $24.84
  • Technical
  • Relative Strength Index (RSI)
  • COEP 55.25
  • FEAM 49.61
  • Support Level
  • COEP $12.09
  • FEAM $3.35
  • Resistance Level
  • COEP $13.53
  • FEAM $4.50
  • Average True Range (ATR)
  • COEP 0.74
  • FEAM 0.32
  • MACD
  • COEP -0.14
  • FEAM 0.04
  • Stochastic Oscillator
  • COEP 53.57
  • FEAM 45.82

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

Share on Social Networks: